Can a 50-year-old woman with Wolff-Parkinson-White syndrome safely use cannabis?

Cannabis Use in WPW Syndrome: Not Recommended

A 50-year-old woman with Wolff-Parkinson-White syndrome should avoid cannabis use due to the risk of triggering life-threatening arrhythmias, particularly atrial fibrillation that can degenerate into ventricular fibrillation through the accessory pathway.

Why Cannabis is Dangerous in WPW

The primary concern is that cannabis can precipitate atrial fibrillation 1, which is particularly dangerous in WPW patients. When atrial fibrillation occurs in someone with WPW syndrome, it can conduct rapidly through the accessory pathway (especially if the pathway has a short refractory period <250 ms), leading to extremely fast ventricular rates that can degenerate into ventricular fibrillation and sudden cardiac death 2.

The Mechanism of Risk

• Sympathetic stimulation from cannabis (similar to exercise, anxiety, or alcohol) can shorten the refractory period of the accessory pathway 3, making rapid conduction more likely
• Cannabis is associated with increased arrhythmia risk, particularly atrial fibrillation, with higher risk in younger users 1
• The risk is compounded by the fact that sudden cardiac death can be the first manifestation of WPW syndrome in approximately 50% of cardiac arrest cases 4

Risk Stratification Context

While the baseline sudden cardiac death rate in WPW is relatively low (0.15%/year) 3, certain factors increase risk:

• Short RR intervals (<250 ms) during atrial fibrillation
• History of symptomatic tachycardia
• Multiple accessory pathways
• Posteroseptal pathway location 3

Cannabis use adds an avoidable trigger to this already present risk, similar to how methamphetamines and cocaine have been documented to precipitate fatal arrhythmias in WPW patients 5, 6.

Clinical Recommendation Algorithm

For this patient:

1. Advise complete avoidance of cannabis (both THC and CBD products)

2. Refer for cardiology evaluation if not already done, specifically for:

   • Electrophysiological study to assess accessory pathway characteristics
   • Risk stratification for sudden cardiac death
   • Consideration of catheter ablation, which is curative and recommended for symptomatic patients 2, 7

3. If symptomatic or high-risk features present: Catheter ablation is the definitive treatment and eliminates the arrhythmia substrate entirely 2, 7

Important Caveats

• Even if the patient is currently asymptomatic, approximately 50% of WPW patients have no history of arrhythmias before a potentially fatal event 3
• The increasing THC content in modern cannabis products amplifies the arrhythmogenic risk 1
• Synthetic cannabinoids are even more dangerous than natural cannabis and should be strictly avoided 1
• If the patient has already undergone successful catheter ablation of the accessory pathway, the WPW-specific risk is eliminated, though general cardiovascular effects of cannabis would still apply

What NOT to Do

If this patient develops pre-excited atrial fibrillation, the following medications are contraindicated and potentially harmful as they can accelerate ventricular rate:

• Amiodarone (IV)
• Adenosine
• Digoxin
• Calcium channel blockers (diltiazem, verapamil)
• Beta-blockers (ineffective and potentially harmful) 2, 7, 8

Bottom line: The combination of WPW syndrome and cannabis represents an unnecessary and potentially lethal risk. Definitive treatment with catheter ablation should be strongly considered, which would eliminate the arrhythmia substrate and allow safer lifestyle choices.